Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ankylosing spondylitis refractory to tumor necrosis factor blockade responds to tocilizumab.

× No keyword cloud information.

11 in total

Review 1. Impact of biological therapy on spondyloarthritis.

Authors: Nicola Maruotti; Francesco Paolo Cantatore
Journal: Eur J Clin Pharmacol Date: 2014-06-10 Impact factor: 2.953

Review 2. Biologic therapies for spondyloarthritis: what is new?

Authors: Xenofon Baraliakos; Juergen Braun
Journal: Curr Rheumatol Rep Date: 2012-10 Impact factor: 4.592

3. Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.

Authors: Atsushi Ogata; Toshio Tanaka
Journal: Int J Rheumatol Date: 2012-01-18

4. All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro Study.

Authors: Deng Li; Peng Wang; Yuxi Li; Zhongyu Xie; Le Wang; Hongjun Su; Wen Deng; Yanfeng Wu; Huiyong Shen
Journal: Stem Cells Int Date: 2015-06-01 Impact factor: 5.443

5. Pathological role of interleukin-6 in psoriatic arthritis.

Authors: Atsushi Ogata; Atsushi Kumanogoh; Toshio Tanaka
Journal: Arthritis Date: 2012-10-11

Review 6. Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.

Authors: Toshio Tanaka; Tadamitsu Kishimoto
Journal: Int J Biol Sci Date: 2012-10-24 Impact factor: 6.580

Review 7. How to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.

Authors: Chung-Tei Chou
Journal: Clin Dev Immunol Date: 2013-06-11

8. Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN).

Authors: Joachim Sieper; Jürgen Braun; Jonathan Kay; Salvatore Badalamenti; Allen R Radin; Lixia Jiao; Stefano Fiore; Tanya Momtahen; George D Yancopoulos; Neil Stahl; Robert D Inman
Journal: Ann Rheum Dis Date: 2014-02-18 Impact factor: 19.103

9. Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.

Authors: Hanna Przepiera-Będzak; Katarzyna Fischer; Marek Brzosko
Journal: Mediators Inflamm Date: 2015-08-03 Impact factor: 4.711

10. Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials.

Authors: Joachim Sieper; Benjamin Porter-Brown; Liz Thompson; Olivier Harari; Maxime Dougados
Journal: Ann Rheum Dis Date: 2013-06-13 Impact factor: 19.103